XCR Diagnostics, Inc.

Part of Fluoresentric, Inc.

UEI
RQDPRJPLWHA8
CAGE
88QF4
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
xcrdiagnostics.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

XCR Diagnostics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Cbot a singleplex Contract · 75D30123P17829 CDC Pittsburgh $211,771
Laboratory supplies - reagents Contract · 75D30122P13540 CDC Pittsburgh $203,805
Laboratory supplies - cbot singleplex assays Contract · 75D30121P10649 CDC Pittsburgh $174,160
Laboratory supplies - cbot singleplex assays Contract · 75D30120P08003 CDC Pittsburgh $151,410
Singleplex assays Contract · 75D30119P04663 CDC Pittsburgh $147,000

About XCR Diagnostics, Inc.

Written by GovTribe AI ·

XCR Diagnostics, Inc. is a manufacturer of goods focused on molecular diagnostics testing. According to its website, the company has developed patented amplification technology for hyper accurate testing near point of care to improve time to results. XCR Diagnostics, Inc. provides goods and services to the Centers for Disease Control and Prevention (CDC), including laboratory supplies and reagents, as well as CBOT singleplex assays used for diagnostic testing.

Through past prime federal contract awards, XCR Diagnostics, Inc. has provided CBOT singleplex assays, laboratory supplies, and reagents to the CDC. Specifically, the company was awarded multiple CDC purchase orders out of Pittsburgh, Pennsylvania from 2019-2023, valued between $147,000-$211,771 for CBOT singleplex assays, laboratory reagents, and related supplies. The purchase orders had no set aside designations and supported CDC facilities in Pittsburgh and Atlanta. Delivery dates ranged from 2019-2023. As the CDC works to control and prevent disease, injury, and disability, these contracts likely supported the agency's diagnostic testing capabilities.

Quick answers

What is XCR Diagnostics, Inc.'s UEI?

XCR Diagnostics, Inc.'s Unique Entity ID (UEI) in SAM.gov is RQDPRJPLWHA8.

What is XCR Diagnostics, Inc.'s CAGE code?

XCR Diagnostics, Inc.'s CAGE code is 88QF4.

What is XCR Diagnostics, Inc.'s primary NAICS code?

XCR Diagnostics, Inc.'s primary NAICS code is 621511 (Medical Laboratories).

Is XCR Diagnostics, Inc. registered in SAM.gov?

XCR Diagnostics, Inc.'s SAM.gov registration expired on January 11, 2025.

Who is XCR Diagnostics, Inc.'s parent company?

XCR Diagnostics, Inc. is part of Fluoresentric, Inc.

What is XCR Diagnostics, Inc.'s most recent federal award?

XCR Diagnostics, Inc.'s most recent federal contract award is Cbot a singleplex (75D30123P17829), from CDC Pittsburgh, on September 12, 2023.

On GovTribe

See XCR Diagnostics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login